85
Participants
Start Date
March 4, 2020
Primary Completion Date
July 11, 2021
Study Completion Date
July 11, 2021
Linagliptin
drug
Acarbose
drug
No.731 Hospital of China Aerospace Science & Industry Corp., Beijing
Shanghai TCM-Integrated Hospital, Shanghai
Nanjing Drum Tower Hospital, Nanjing
Zhongda Hospital Southeast University, Nanjing
Zhangjiagang First People Hospital, Suzhou
Huai'an first people's hospital, Huai'an
Dongying People's Hospital, Dongying
ChongQing The Fourth Hospital, Chongqing
Southern Medical University Shenzhen Hospital, Shenzhen
Affiliated Hospital of Chengdu University, Chengdu
Lead Sponsor
Boehringer Ingelheim
INDUSTRY